Skip to main content
. 2019 Feb 14;28(5):1191–1199. doi: 10.1007/s11136-019-02117-9

Table 2.

Observed values from VAS and TTO exercises for all health states

Health state VAS value (n = 200)
Mean (SD)
TTO value (n = 200)
Mean (SD)
Base State 1 (receiving ADT) 49.4 (19.1) 0.71 (0.26)
Base State 2 (receiving docetaxel + ADT) 42.4 (18.0) 0.64 (0.27)
Base State 3 (completed docetaxel + on ADT; not progressed) 46.0 (18.5) 0.68 (0.26)
AEs (Base State 2 + specific AE)
 Fatigue 34.9 (16.8) 0.54 (0.34)
 Nausea and vomiting 26.6 (15.4) 0.41 (0.36)
 Reduced immunity 30.9 (15.8) 0.48 (0.33)
 Fluid retention 36.7 (16.4) 0.58 (0.29)
 Alopecia 33.4 (18.7) 0.58 (0.29)
 Diarrhoea 25.6 (15.8) 0.40 (0.38)
Dead 3.9 (7.1)

VAS values from 0 (“worst health”) to 100 (“best health”); TTO values from 0 (“equivalent to being dead”) to 1 (“perfect health”); a negative value would indicate a state worse than being dead

ADT androgen deprivation therapy, AE adverse event, n number, SD standard deviation, TTO time trade-off, VAS visual analogue scale